These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32335034)
1. Assessment of the Vitreomacular Interface Using High-Resolution OCT in a Population-Based Cohort Study of Older Adults. Quinn NB; Steel DH; Chakravarthy U; Peto T; Hamill B; Muldrew A; Graham K; Elliott D; Hennessy R; Cruise S; McGuinness B; Young IS; Kee F; Hogg RE Ophthalmol Retina; 2020 Aug; 4(8):801-813. PubMed ID: 32335034 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Vitreoretinal Interface Disorders in an Australian Population: The Blue Mountains Eye Study. Liew G; Nguyen H; Ho IV; White AJ; Burlutsky G; Gopinath B; Mitchell P Ophthalmol Sci; 2021 Jun; 1(2):100019. PubMed ID: 36249297 [TBL] [Abstract][Full Text] [Related]
3. OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation. Liao DY; Liu JH; Zheng YP; Shiu HW; Wang JM; Chao HM BMC Ophthalmol; 2020 Apr; 20(1):163. PubMed ID: 32321473 [TBL] [Abstract][Full Text] [Related]
4. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study. Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Vitreoretinal Interface Abnormalities as Detected by Spectral-Domain Optical Coherence Tomography. Jacob J; Stalmans P Ophthalmologica; 2016; 236(2):81-7. PubMed ID: 27287013 [TBL] [Abstract][Full Text] [Related]
6. Vitreomacular Adhesion and Its Association With Age-Related Macular Degeneration in a Population-Based Setting: The Alienor Study. Gattoussi S; Cougnard-Grégoire A; Delyfer MN; Rougier MB; Schweitzer C; Delcourt C; Korobelnik JF Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2180-2186. PubMed ID: 28399268 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Koizumi H; Spaide RF; Fisher YL; Freund KB; Klancnik JM; Yannuzzi LA Am J Ophthalmol; 2008 Mar; 145(3):509-517. PubMed ID: 18191099 [TBL] [Abstract][Full Text] [Related]
8. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Stalmans P Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900 [TBL] [Abstract][Full Text] [Related]
9. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA; Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327 [TBL] [Abstract][Full Text] [Related]
11. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Duker JS; Kaiser PK; Binder S; de Smet MD; Gaudric A; Reichel E; Sadda SR; Sebag J; Spaide RF; Stalmans P Ophthalmology; 2013 Dec; 120(12):2611-2619. PubMed ID: 24053995 [TBL] [Abstract][Full Text] [Related]
12. The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Meuer SM; Myers CE; Klein BE; Swift MK; Huang Y; Gangaputra S; Pak JW; Danis RP; Klein R Ophthalmology; 2015 Apr; 122(4):787-95. PubMed ID: 25556116 [TBL] [Abstract][Full Text] [Related]
13. Vitreomacular Adhesion and the Risk of Neovascular Age-Related Macular Degeneration. Maggio E; Polito A; Guerriero M; Prigione G; Parolini B; Pertile G Ophthalmology; 2017 May; 124(5):657-666. PubMed ID: 28214102 [TBL] [Abstract][Full Text] [Related]